Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis.

endothelial progenitor cells idiopathic pulmonary fibrosis interstitial lung disease rheumatoid arthritis vascular damage biomarker

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 09 11 2020
revised: 09 12 2020
accepted: 14 12 2020
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 24 12 2020
Statut: epublish

Résumé

Interstitial lung disease (ILD) increases morbidity and mortality in patients with rheumatoid arthritis (RA). Although the pathogenesis of ILD associated with RA (RA-ILD

Identifiants

pubmed: 33353104
pii: jcm9124098
doi: 10.3390/jcm9124098
pmc: PMC7766338
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : This work was partially supported by the European Regional Development Fund (ERDF) and `Fondo de Investigación Sanitaria´ [PI18/00043] from Instituto de Salud Carlos III (ISCIII), Health Ministry, Spain.
ID : PI18/00043

Références

Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L419-30
pubmed: 18065657
Arthritis Rheum. 2009 Nov;60(11):3168-79
pubmed: 19877034
Angiogenesis. 2013 Jan;16(1):147-57
pubmed: 22983452
Ann Rheum Dis. 2009 Feb;68(2):163-8
pubmed: 18653485
J Am Coll Cardiol. 2005 May 3;45(9):1441-8
pubmed: 15862416
Arthritis Res Ther. 2010;12(1):R27
pubmed: 20158894
BMC Med. 2015 Nov 09;13:277
pubmed: 26552487
Rev Invest Clin. 2015 Sep-Oct;67(5):280-6
pubmed: 26696331
PLoS One. 2010 Nov 03;5(11):e13790
pubmed: 21072182
Clin Exp Rheumatol. 2008 Jul-Aug;26(4):680-7
pubmed: 18799106
Science. 1997 Feb 14;275(5302):964-7
pubmed: 9020076
BMJ. 2016 Feb 24;352:h6819
pubmed: 26912511
Joint Bone Spine. 2008 Mar;75(2):131-7
pubmed: 18314371
Rheumatology (Oxford). 2012 Oct;51(10):1775-84
pubmed: 22753774
Int J Cardiol. 2013 Sep 1;167(5):1688-95
pubmed: 23171577
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
J Clin Med. 2019 Nov 21;8(12):
pubmed: 31766446
Lancet Respir Med. 2018 Feb;6(2):138-153
pubmed: 29154106
Stem Cells Int. 2016;2016:8043792
pubmed: 26839569
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Eur Respir J. 2011 Feb;37(2):426-31
pubmed: 21282810
J Clin Med. 2020 May 26;9(6):
pubmed: 32466389

Auteurs

Verónica Pulito-Cueto (V)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.

Sara Remuzgo-Martínez (S)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.

Fernanda Genre (F)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.

Víctor M Mora-Cuesta (VM)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

David Iturbe-Fernández (D)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Sonia Fernández-Rozas (S)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Belén Atienza-Mateo (B)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
López Albo' Post-Residency Programme, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Leticia Lera-Gómez (L)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.

Pilar Alonso-Lecue (P)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Javier Rodríguez-Carrio (J)

Department of Functional Biology, Immunology Area, Faculty of Medicine, Universidad de Oviedo, Oviedo, 33006 Asturias, Spain.

Diana Prieto-Peña (D)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Virginia Portilla (V)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Ricardo Blanco (R)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Alfonso Corrales (A)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.

Oreste Gualillo (O)

SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago University Clinical Hospital, Santiago de Compostela, 15706 A Coruña, Spain.

José M Cifrián (JM)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.
School of Medicine, Universidad de Cantabria, Santander, 39005 Cantabria, Spain.

Raquel López-Mejías (R)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.

Miguel A González-Gay (MA)

Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Santander, 39011 Cantabria, Spain.
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008 Cantabria, Spain.
School of Medicine, Universidad de Cantabria, Santander, 39005 Cantabria, Spain.
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2050, South Africa.

Classifications MeSH